Differential sensitivity to platinum-based chemotherapy in primary uterine serous papillary carcinoma cell lines with high vs low HER-2/neu expression in vitro.
about
hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma.Development of targeted therapy in uterine serous carcinoma, a biologically aggressive variant of endometrial cancerUterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody.Primary peritoneal serous carcinoma: a clinicopathological and immunohistochemical study of six cases.Individuality in FGF1 expression significantly influences platinum resistance and progression-free survival in ovarian cancerNovel MicroRNAs regulating proliferation and apoptosis in uterine papillary serous carcinomas.Tubulin-β-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones.Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapyImproved i.p. drug delivery with bioadhesive nanoparticles.Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma.
P2860
Q34253625-7C29C6A4-C662-4BF9-889C-1596098BBE4BQ34634149-717B85A3-6456-4664-A9F7-186891EEB52DQ35083850-5C21CAF4-C699-43E2-B5A8-196729F46002Q36305409-7DACF960-10CC-465E-B118-11B5BAEC3249Q36387788-B3A12BDE-7B12-496F-A400-1CAE13490D25Q36893313-085F0C95-20C8-4376-9476-C652BB4A6A98Q36980135-1357095D-2AAE-40F6-AE0E-F1973DC1ED2AQ37040655-834482D6-C529-47F2-918D-736265688E05Q37346875-8A8CCC42-0C1E-4735-B8B8-EC595D8CC933Q41624093-4BFD891A-F053-4E3B-9C2B-59905EA0DEF8
P2860
Differential sensitivity to platinum-based chemotherapy in primary uterine serous papillary carcinoma cell lines with high vs low HER-2/neu expression in vitro.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Differential sensitivity to pl ...... HER-2/neu expression in vitro.
@ast
Differential sensitivity to pl ...... HER-2/neu expression in vitro.
@en
Differential sensitivity to pl ...... HER-2/neu expression in vitro.
@nl
type
label
Differential sensitivity to pl ...... HER-2/neu expression in vitro.
@ast
Differential sensitivity to pl ...... HER-2/neu expression in vitro.
@en
Differential sensitivity to pl ...... HER-2/neu expression in vitro.
@nl
prefLabel
Differential sensitivity to pl ...... HER-2/neu expression in vitro.
@ast
Differential sensitivity to pl ...... HER-2/neu expression in vitro.
@en
Differential sensitivity to pl ...... HER-2/neu expression in vitro.
@nl
P2093
P2860
P1476
Differential sensitivity to pl ...... HER-2/neu expression in vitro.
@en
P2093
Alessandro D Santin
Christine E Richter
Emiliano Cocco
Eric R Siegel
Peter E Schwartz
Sarah N Cross
Stacey L Brower
Stefania Bellone
Thomas J Rutherford
Valsamo K Anagnostou
P2860
P304
P356
10.1016/J.AJOG.2010.02.056
P407
P577
2010-04-24T00:00:00Z